Citigroup’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Buy |
60,134
+16,013
| +36% | +$141K | ﹤0.01% | 2893 |
|
|
2025
Q1 | $330K | Sell |
44,121
-7,163
| -14% | -$53.7K | ﹤0.01% | 3148 |
|
|
2024
Q4 | $428K | Buy |
51,284
+20,753
| +68% | +$173K | ﹤0.01% | 3126 |
|
|
2024
Q3 | $212K | Buy |
30,531
+21,199
| +227% | +$147K | ﹤0.01% | 3536 |
|
|
2024
Q2 | $45.7K | Buy |
9,332
+2,279
| +32% | +$11.2K | ﹤0.01% | 3901 |
|
|
2024
Q1 | $40.9K | Buy |
7,053
+1,675
| +31% | +$9.72K | ﹤0.01% | 3978 |
|
|
2023
Q4 | $35.2K | Buy |
5,378
+5,360
| +29,778% | +$35.1K | ﹤0.01% | 3955 |
|
|
2023
Q3 | $87 | Sell |
18
-10,314
| -100% | -$49.9K | ﹤0.01% | 4671 |
|
|
2023
Q2 | $52.7K | Sell |
10,332
-48,164
| -82% | -$246K | ﹤0.01% | 3939 |
|
|
2023
Q1 | $322K | Sell |
58,496
-13,250
| -18% | -$72.9K | ﹤0.01% | 2845 |
|
|
2022
Q4 | $329K | Buy |
71,746
+67,717
| +1,681% | +$311K | ﹤0.01% | 2781 |
|
|
2022
Q3 | $25K | Buy |
4,029
+3,186
| +378% | +$19.8K | ﹤0.01% | 3947 |
|
|
2022
Q2 | $4K | Sell |
843
-1,293
| -61% | -$6.14K | ﹤0.01% | 4944 |
|
|
2022
Q1 | $11K | Sell |
2,136
-6,699
| -76% | -$34.5K | ﹤0.01% | 4709 |
|
|
2021
Q4 | $77K | Buy |
8,835
+5,578
| +171% | +$48.6K | ﹤0.01% | 4101 |
|
|
2021
Q3 | $30K | Buy |
3,257
+1,897
| +139% | +$17.5K | ﹤0.01% | 4286 |
|
|
2021
Q2 | $17K | Buy |
+1,360
| New | +$17K | ﹤0.01% | 4727 |
|
|
2016
Q4 | – | Sell |
-148
| Closed | -$11K | – | 4979 |
|
|
2016
Q3 | $11K | Buy |
148
+39
| +36% | +$2.9K | ﹤0.01% | 4421 |
|
|
2016
Q2 | $7K | Sell |
109
-5
| -4% | -$321 | ﹤0.01% | 4632 |
|
|
2016
Q1 | $26K | Sell |
114
-13
| -10% | -$2.97K | ﹤0.01% | 4515 |
|
|
2015
Q4 | $40K | Buy |
+127
| New | +$40K | ﹤0.01% | 4203 |
|